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nulation remains widely accepted and pop-
ularized for reasons that remain unclear.
This is despite the fact that it is the most
“physiologic” approach in establishing car-
diopulmonary bypass in acute type A aortic
dissection. We have been using this tech-
nique exclusively since 1995 for the rea-
sons outlined by Dr Wada and associates.
However, we would like to share additional
valuable comments that our experience has
demonstrated.
Although placement of the aortic cannula
through the aortic valve into the true lumen is
desirable, it is not essential. In some cases of
cardiomegaly we found that the cannula was
too short to traverse the aortic valve. The tip
was therefore guided into the left ventricular
outflow tract under transesophageal echocar-
diography. We encountered no compromise
in perfusion pressures, flow rates, or ventric-
ular distension. Furthermore, although Dr
Wada and colleagues suggest that the tech-
nique is not practical after previous cardiac
surgery, our experience is to the contrary. We
recently used the transapical approach in a
patient who presented with recurrent type A
aortic dissection some years after his initial
presentation. The dissection flap involved
both femoral arteries and neck vessels, pre-
cluding all other sites for extrathoracic can-
nulation. The left ventricular apex was easily
exposed through a small left thoracotomy
and a 21F Bio-Medicus cannula (Medtronic,
Minneapolis, Minn) introduced through a
stab incision. The presence of such patients
with no option for extrathoracic cannulation
because of extensive dissection is not un-
common, and they would otherwise be
denied surgery. However, perfusion of
the true lumen can be ensured with the
transapical approach.
The theoretic disadvantages to the ap-
proach include potential problems with the
stab incision repair. Our arterial cannula is
designed for percutaneous femoral cannu-
lation and has a rigid sharp introducer. Our
stab incision, which measures less than
4 mm, is not full thickness because the myo-
cardium is split along the fibers by the
cannula rather than cut by a knife. In our
experience the size of the wound is similar
to that when an apical vent is used for
conventional aortic valve replacement. Be-
cause of the small wound size, we do not
routinely use pledgets for repair but place a
horizontal mattress 4-0 polypropylene su-
ture with an over-and-over running suture.
To date we have encountered no technical
difficulty with the repair site.
In conclusion, our experience supports
the use of transapical cannulation as the
method of choice for arterial inflow in type A
dissection. We strongly advocate its routine
use and are grateful to Dr Wada and col-
leagues for confirming it in their large series.
Rajwinder S. Jutley, MD, MRCS
Nicola Masala, MD
A. W. Sosnowski, MD, FRCS
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Glenfield Hospital
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Reply to the Editor:
We appreciate the comments of Dr Jutley
and colleagues concerning our recent arti-
cle.1 As they said, transapical aortic can-
nulation is the most physiologic approach
to establish cardiopulmonary bypass in
type A aortic dissection.
We would like to give some additional
explanation related to their comments. Our
cannula is long enough to traverse the aor-
tic valve in patients with cardiomegaly
(Figure 1, A). It is necessary that our stab
incision, which measures approximately
1 cm, be full-thickness myocardium be-
cause the tip of this cannula is not sharp
(Figure 1, B). As a result, we routinely
close the incision with a few (usually 3) 4-0
polyvinylidene fluoride interrupted sutures
with felt pledgets. There were no bleeding
problems after performing stab-wound can-
nulation and closing the incision with this
technique.
Shinichi Wada, MD
Shin Yamamoto, MD, PhD
Yasuyuki Hosoda, MD
Aortic Center
Kawasaki Saiwai Hospital
Kanagawa, Japan
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Off-pump coronary artery bypass
sacrifices graft patency
To the Editor:
We are grateful to Dr Gardner1 for his
editorial regarding our meta-analysis2 of
randomized controlled trials of off-pump
coronary artery bypass (OPCAB) versus
conventional coronary artery bypass graft-
ing (CABG), and we absolutely agree with
his statement: “the choice of which tech-
nique (of OPCAB or CABG) to use should
remain the surgeon’s option.” However,
we, in the era of evidence-based medicine,
are convinced that the surgeon’s option
should be based on the best evidence, such
as a meta-analysis of randomized con-
trolled trials (type Ia evidence recom-
mended by the Agency for Health Care
Policy and Research).
The meta-analysis of 37 randomized tri-
als (3369 patients) of OPCAB versus
CABG by Cheng and associates,3 pub-
lished in 2005, demonstrated that no sig-
nificant differences were found for 30-day
mortality, myocardial infarction, stroke, re-
nal dysfunction, intraaortic balloon pump,
wound infection, rethoracotomy, or reinter-
vention. However, OPCAB significantly
decreased arterial fibrillation, transfusion,
inotrope requirements, respiratory infec-
tions, ventilation time, intensive care unit
stay, and hospital stay.3 Therefore, OPCAB
Figure 1. Sarns Soft-flow Extended Aortic
Cannula (Terumo Cardiovascular Systems,
Corp, Ann Arbor, Mich).
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surpasses CABG in these selected short-
term and mid-term clinical and resource
outcomes. On the other hand, as far as
bypass graft patency is concerned, CABG
is superior to OPCAB according to several
more recent meta-analyses of randomized
controlled trials, including our meta-
analysis.2,4,5 The choice of which tech-
nique of OPCAB or CABG to use
should be based not on the clinical ex-
periences of respected authorities (type IV
evidence) but on the above-mentioned best
evidence.
We completely agree with Dr Gardner’s
statement: “Were it (OPCAB) not for our
young colleagues who have championed
OPCAB, the option of successfully using
this approach when preferable to conven-
tional CABG surgery would not exist to-
day.” We emphasize that OPCAB should
not be performed when preferable to
CABG because OPCAB sacrifices graft pa-
tency in such patients as were enrolled in
the randomized controlled trials reviewed
in our meta-analysis.
Hisato Takagi, MD, PhD
Takayoshi Kato, MD
Takuya Umemoto, MD, PhD
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Precise quantification of
pressure-flow waveforms during
pulsatile and nonpulsatile perfusion
To the Editor:
We would like to congratulate Kassab and
colleagues1 on their experimental design
and results concerning pulsatile cardiople-
gic delivery in improved subendocardial
perfusion of the open failing ventricle
when compared with nonpulsatile perfu-
sion. We believe that their investigation is
a good attempt to use pulsatile flow as a
myocardial protective strategy during the
cardiopulmonary bypass (CPB) procedure.
Such information may be critical to en-
hance cardioprotective strategies in cardiac
patients in the near future.
We would like to make several com-
ments concerning direct comparison be-
tween pulsatile and nonpulsatile modes.
We believe that it is essential to acquire
precise quantification of pressure and pump-
flow waveforms during direct comparison
between perfusion modes.2,3 It is insuffi-
cient to use the pulse pressure as the only
criteria to define the pulsatile flow, because
the generation of pulsatile flow depends
on an energy gradient.2-4 In addition to
the pressure waveforms, the pump flow
waveforms should also be included in the
quantification. The precise quantification
of pressure-flow waveforms in terms of
hemodynamic energy, energy equivalent
pressure (EEP), and surplus hemodynamic
energy (SHE) levels is a must. Surplus
hemodynamic energy is the “extra energy”
generated only under adequate pulsatility.
The EEP formula is based on the ratio
between the area beneath the hemodynamic
power curve (fpdt) and the area beneath
the pump flow curve (fdt) during each
pulse cycle4:
EEP (fpdt) ⁄ (fdt)
where f is the pump flow rate, p is the
arterial pressure (mm Hg), and dt indicates
that the integration is performed over time
(t). The unit of the EEP is mm Hg. There-
fore, it is possible to compare the EEP with
the mean arterial pressure (MAP). The dif-
ference between the EEP and MAP is the
extra energy or SHE generated by each
pulsatile or nonpulsatile device.
In our studies on myocardial flow in
direct comparison between two different
modes in terms of EEP and SHE, pulsatile
perfusion produced significantly higher he-
modynamic energy than did nonpulsatile
perfusion during CPB.2,3,5 The pulsatile
group had significantly better myocardial
blood flow than had the nonpulsatile group;
particularly, pulsatile flow improved left-
and right-ventricular blood flow after 60
minutes of ischemia and hypothermic CPB
in a piglet model.5 In a recent clinical
study, it has also been clearly documented
that pulsatile flow resulted in significantly
less inotropic support, shorter intubation
time, and shorter duration of intensive care
unit stay and hospital stay in 50 pediatric
CPB patients.6
We congratulate the authors for their
promising results and strongly suggest that
they consider using the EEP and SHE for-
mulas for direct comparisons of pulsatile
and nonpulsatile perfusion for their future
experiments.
Bingyang Ji, MD
Akif U¨ ndar, PhD
Department of Pediatrics
Department of Surgery
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